日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Diverse combination of factors associated with the development of diabetic kidney disease among data-driven diabetes subtypes: analysis of the J-DREAMS registry

基于数据驱动的糖尿病亚型中与糖尿病肾病发展相关的多种因素:J-DREAMS注册研究分析

Watanabe-Shimoji, Kiriko; Tanabe, Hayato; Ohsugi, Mitsuru; Kawakami, Eiryo; Tanaka, Kenichi; Kazama, Junichiro J; Ueki, Kohjiro; Shimabukuro, Michio

Association between steatotic liver disease and post-traumatic stress symptoms in the Fukushima health management survey

福岛健康管理调查中脂肪肝疾病与创伤后应激症状之间的关联

Hayashi, Fumikazu; Ohira, Tetsuya; Takahashi, Atsushi; Ueda, Yuka; Nakano, Hironori; Okazaki, Kanako; Nagao, Masanori; Sato, Shiho; Maeda, Masaharu; Miura, Itaru; Shimabukuro, Michio; Sakai, Akira; Kazama, Junichiro James; Ohto, Hitoshi; Yasumura, Seiji

Trends in heart failure prevalence in post-disaster Fukushima residents 2015-2021

2015-2021年福岛核事故后居民心力衰竭患病率趋势

Ma, Enbo; Ohira, Tetsuya; Fukasawa, Maiko; Shirafuji, Atsushi; Ohira, Hiromasa; Shimabukuro, Michio

Association between mean platelet volume and kidney events in patients with type 2 diabetes mellitus

2型糖尿病患者平均血小板体积与肾脏事件之间的关联

Watanabe, Syuhei; Tanaka, Kenichi; Kimura, Hiroshi; Saito, Hirotaka; Shimabukuro, Michio; Asahi, Koichi; Watanabe, Tsuyoshi; Kazama, Junichiro James

Advances in Beyond Statin Lipid Therapies for ASCVD Risk Reduction

他汀类药物以外的降脂疗法在降低动脉粥样硬化性心血管疾病风险方面的进展

Shimabukuro, Michio

Lipid Management for Secondary Prevention in Atherosclerotic Cardiovascular Disease: A Scoping Review and Scientific Report

动脉粥样硬化性心血管疾病二级预防中的血脂管理:范围界定综述和科学报告

Tanaka, Atsushi; Oyama, Kazuma; Yakushiji, Yusuke; Natsuaki, Masahiro; Mizuno, Atsushi; Saito, Yuichi; Matsumoto, Shingo; Yamagami, Hiroshi; Kunieda, Takenobu; Shibata, Shigeru; Nishimoto, Mitsuhiro; Ayuzawa, Nobuhiro; Shimabukuro, Michio; Tsuchiya, Kyoichiro; Okazaki, Hiroaki; Nomura, Akihiro; Kaneko, Hidehiro; Kohsaka, Shun; Yoshida, Masayuki; Harada-Shiba, Mariko; Shimano, Hitoshi; Node, Koichi

Diversity of Dyslipidemia in MASLD, MetALD, and ALD: Different Profiles of Small Dense LDL Cholesterol

MASLD、MetALD 和 ALD 中血脂异常的多样性:小而密 LDL 胆固醇的不同特征

Shimabukuro, Michio

Association of severe stress with the onset of chronic kidney disease after the Great East Japan Earthquake: the Fukushima Health Management Survey

严重应激与东日本大地震后慢性肾脏病发病的相关性:福岛健康管理调查

Kazama, Sakumi; Hayashi, Fumikazu; Tanaka, Kenichi; Sato, Shiho; Ueda, Yuka; Okazaki, Kanako; Ohira, Tetsuya; Sakai, Akira; Maeda, Masaharu; Yabe, Hirooki; Hosoya, Mitsuaki; Takahashi, Atsushi; Nakano, Hironori; Nagao, Masanori; Shimabukuro, Michio; Ohto, Hitoshi; Yasumura, Seiji; Kazama, Junichiro J

Impact of baseline left ventricular ejection fraction and body mass index on the effect of 24-week Ipragliflozin treatment on left ventricular diastolic function in patients with type 2 diabetes and chronic kidney disease: insights from the PROCEED trial

基线左心室射血分数和体重指数对 24 周伊格列净治疗对 2 型糖尿病合并慢性肾脏病患者左心室舒张功能的影响:来自 PROCEED 试验的启示

Teragawa, Hiroki; Tanaka, Atsushi; Takahashi, Kanae; Oshita, Chikage; Uchimura, Yuko; Kamei, Nozomu; Hirai, Hiroyuki; Shimabukuro, Michio; Taguchi, Isao; Okada, Yosuke; Node, Koichi

Effects of finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomised placebo-controlled mechanistic trial (FIVE-STAR)

非奈利酮对 2 型糖尿病合并慢性肾病患者动脉僵硬和心肾生物标志物的影响:一项随机安慰剂对照机制试验(FIVE-STAR)

Tanaka, Atsushi; Vaduganathan, Muthiah; Imai, Takumi; Okada, Yosuke; Sonoda, Satomi; Torimoto, Keiichi; Suwa, Satoru; Teragawa, Hiroki; Miyazono, Motoaki; Fukuda, Makoto; Yonezu, Keisuke; Takahashi, Naohiko; Yoshida, Yuichi; Tanaka, Kenichi; Shimabukuro, Michio; Hotta, Yuki; Moroi, Masao; Niikura, Hiroki; Kida, Keisuke; Yokota, Kenichi; Fukuda, Daiju; Tanabe, Kengo; Horiuchi, Yu; Toyoda, Shigeru; Taguchi, Isao; Yoshida, Hisako; Miyoshi, Toru; Nangaku, Masaomi; Shibata, Hirotaka; Node, Koichi